About 2 Trademarks found for “LYEL*”

Pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases, namely, respiratory infections, eye infections, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, eczema, and sexually transmitted diseases; cells for medical or clinical purposes, namely, genetically modified immune cells made from human blood cells for cell therapy, epigenetically modified immune cells made from human blood cells for cell therapy, rejuvenated and partially reprogrammed human blood cells for cell therapy, biological preparations made from human immune blood cells, rejuvenated somatic cells, and rejuvenated and partially reprogrammed human blood cells for the treatment of cancer; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of stem cells for medical purposes and pharmaceutical preparations for the treatment of cancer, auto-immune diseases, and infectious diseases, namely, respiratory infections, eye infections, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, eczema, and sexually transmitted diseases

custom manufacturing services of pharmaceuticals

Pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases, namely, sexually transmitted diseases, respiratory infections, eye infections, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, and eczema; cells for medical or clinical purposes, namely, genetically modified human immune cells for cell therapy, epigenetically modified human immune cells for cell therapy, rejuvenated and partially reprogrammed human cells for cell therapy, biological preparations made from human immune cells, rejuvenated somatic cells, and rejuvenated and partially reprogrammed human cells for the treatment of cancer; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of genetically modified human immune cells for cell therapy, epigenetically modified human immune cells for cell therapy, rejuvenated and partially reprogrammed human cells for cell therapy, biological preparations made from human immune cells, rejuvenated somatic cells, and rejuvenated and partially reprogrammed human cells for the treatment of cancer cells for medical purposes and pharmaceutical preparations for the treatment of sexually transmitted diseases, cancer, auto immune diseases, and infectious diseases, namely, sexually transmitted diseases, respiratory infections, eye infections, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, and eczema

Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development in the field of pharmaceuticals and biopharmaceuticals; medical research laboratory services; medical and scientific research in the field of pharmaceuticals and biopharmaceuticals; conducting clinical trial regarding pharmaceutical preparations and drugs for the treatment of cancer, auto immune diseases, and infectious diseases; conducting clinical trial regarding pharmaceutical preparations and drugs in the field of immunotherapy; conducting clinical trial regarding pharmaceutical preparations and drugs in the field cell therapy